Hims & Hers Health, Inc.
NYSE: HIMS
Drug Manufacturers - Specialty & Generic
United States
Cap: $6.931,7 M
$27,17
$-0,55 (-2,00%)
Precio Histórico
$-35,59 (-56,72%) en 1 Año
Estimaciones de Analistas
Datos al 15/10/2026
Precio Objetivo
Precio Objetivo Promedio
$31,15
+14,7% vs precio actual
Rango de Estimaciones
$23,00 - $42,00
Precio Objetivo Mediana
Basado en 13 analistas$31,00
Consenso de Analistas
Mantener
Consenso 2,8 / 5Estimaciones a Futuro
EPS Año Actual (est.)
$-0,56
EPS Forward (est.)
$0,42
Ventas Forward (est.)
$3.997 M
Indicadores en vivo
Yahoo Finance
Indicadores que cambian con el precio actual (P/E, P/FCF, dividend yield, beta) y cifras del último período. Se actualizan en tiempo real. Los valores en verde indican métricas favorables.
EPS
-0,60
P/E Ratio
N/A
P/FCF
N/A
Dividend Yield
N/A
Profit Margin
-5,51%
Beta
2,43
Ingresos
$2.578,1 M
EBITDA
$-10,2 M
FCF
N/A
Análisis con IA
Reporte ejecutivo generado a partir de los datos de la empresaAnálisis fundamental detallado
Datos al 15/10/2026
Ratios estructurales de valuación, rentabilidad, solvencia y crecimiento, tomados del último balance reportado. Los valores en verde indican métricas favorables.
Valuación
P/B
19,17
EV/EBITDA
-704,79
PEG
2,71
P/S
2,41
Rentabilidad
ROE
-32,03%
ROIC
N/A
ROA
-2,21%
Margen Bruto
69,53%
Margen Operativo
-12,75%
Solvencia
Deuda / Patrimonio
4,77
Current Ratio
0,93
Quick Ratio
0,82
Caja Total
$841 M
Deuda Total
$1.546,2 M
Crecimiento
Crec. Ingresos
38,20%
Crec. Ganancias
N/A
Dividendos
Sin datos de dividendos para este ticker. Puede que la compañía no reparta dividendos.
Últimas noticias
Hims & Hers Expands Australian Women's Health Platform With HersZacks · 14/10/2026
Should You Trim Or Add To Your Hims & Hers Position Now?Trefis · 12/10/2026
Hims & Hers Health Launches Women's Health Platform in AustraliaMT Newswires · 12/10/2026
Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026Business Wire · 12/10/2026
Hers Launches in Australia, Built to Care for the Whole WomanBusiness Wire · 12/10/2026
2 Growth Stocks Set to Flourish and 1 Facing HeadwindsStockStory · 12/10/2026
1 Healthcare Stock Worth Your Attention and 2 We Turn DownStockStory · 09/10/2026
Is Hims & Hers Stock Ready For A Longer Cash Burn?Trefis · 08/10/2026
Yahoo Finance
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total Revenue Ingresos Totales | $2.347,6 M+59,0% | $1.476,5 M+69,3% | $872 M+65,5% | $526,9 M |
Cost of Revenue Costo de Ventas | $614,3 M+102,5% | $303,4 M+93,2% | $157,1 M+32,9% | $118,2 M |
Gross Profit Utilidad Bruta | $1.733,4 M+47,8% | $1.173,1 M+64,1% | $714,9 M+74,9% | $408,7 M |
Research & Development Investigación y Desarrollo | $149,3 M+89,4% | $78,8 M+63,4% | $48,2 M+65,0% | $29,2 M |
Selling, General & Administrative Gastos Generales y Adm. | $1.192 M+40,8% | $846,6 M+46,9% | $576,3 M+55,4% | $370,8 M |
Total Operating Expenses Gastos Operativos Totales | $1.627,8 M+46,5% | $1.111,2 M+49,3% | $744,4 M+55,9% | $477,4 M |
Operating Income Utilidad Operativa | $105,6 M+70,6% | $61,9 M+310,2% | -$29,5 M+57,1% | -$68,7 M |
Goodwill Impairment Loss Pérdida por deterioro de goodwill | — | — | — | — |
Other Income/(Expense), Net Otros Ingresos/(Gastos), Neto | $18,3 M+86,7% | $9,8 M+24,4% | $7,9 M+163,8% | $3 M |
Pretax Income Utilidad Antes de Impuestos | $123,9 M+72,8% | $71,7 M+432,4% | -$21,6 M+67,2% | -$65,7 M |
Tax Provision Impuestos | -$4,4 M+91,8% | -$54,3 M-2.850,7% | $2 M+6.471,0% | -$31,0K |
Net Income Utilidad Neta | $128,4 M+1,8% | $126 M+635,3% | -$23,5 M+64,1% | -$65,7 M |
EBITDA | $160,1 M+102,7% | $79 M+496,2% | -$19,9 M+67,4% | -$61,2 M |
Basic EPS UPA Básica | $0,57-1,7% | $0,58+627,3% | -$0,11+65,6% | -$0,32 |
Diluted EPS UPA Diluida | $0,51-3,8% | $0,53+581,8% | -$0,11+65,6% | -$0,32 |
Transacciones de Insiders
Compras y ventas en el mercado abierto reportadas en formularios SEC Form 4, de los últimos 12 meses. Las compras se muestran en verde y las ventas en rojo. Quedan afuera 26 movimientos de compensación (entrega de acciones, retenciones de impuestos, ejercicios de opciones), que no reflejan una decisión sobre el precio.
Compra
Venta
| Fecha | Insider | Cargo | Operación | Acciones | Precio | Valor total |
|---|---|---|---|---|---|---|
| 22/09/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 29.277 | $29,95 | $876,8K |
| 16/09/2026 | BOUGHTON SOLEIL | Officer | Venta | 6.236 | $27,86 | $173,7K |
| 15/09/2026 | CHI MICHAEL Y | Chief Operating Officer | Venta | 14.027 | $28,39 | $398,2K |
| 15/09/2026 | ELSHENAWY MOHAMED | Chief Technology Officer | Venta | 7.954 | $28,39 | $225,8K |
| 02/09/2026 | BOUGHTON SOLEIL | Officer | Venta | 3.458 | $28,33 | $98,0K |
| 19/08/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 4.938 | $29,99 | $148,1K |
| 19/08/2026 | BOUGHTON SOLEIL | Officer | Venta | 25.111 | $27,55 | $691,8K |
| 18/08/2026 | AUTOR DEBORAH M | Officer and Director | Venta | 16.773 | $27,85 | $467,1K |
| 17/08/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 64.771 | $34,05 | $2,2M |
| 17/07/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 7.163 | $31,99 | $229,2K |
| 06/07/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 7.163 | $36,49 | $261,4K |
| 22/06/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 18.197 | $34,03 | $619,2K |
| 18/06/2026 | CARROLL PATRICK HARRISON | Officer | Venta | 23.726 | $35,00 | $830,4K |
| 17/06/2026 | CHI MICHAEL Y | Chief Operating Officer | Venta | 14.027 | $31,50 | $441,9K |
| 17/06/2026 | ELSHENAWY MOHAMED | Chief Technology Officer | Venta | 30.040 | $31,50 | $946,3K |
| 17/06/2026 | BECKLUND IRENE | Officer | Venta | 12.063 | $30,72 | $370,5K |
| 26/05/2026 | WELLS DAVID B | Director | Compra | 48.400 | $24,24 | $1,2M |
| 18/05/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 7.950 | $23,64 | $187,9K |
| 20/04/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 19.645 | $29,96 | $588,6K |
| 20/04/2026 | BOUGHTON SOLEIL | Officer | Venta | 9.463 | $30,00 | $283,9K |
| 17/04/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 54.927 | $26,53 | $1,5M |
| 06/04/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 3.975 | $19,98 | $79,4K |
| 20/03/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 9.217 | $23,77 | $219,1K |
| 17/03/2026 | CHI MICHAEL Y | Chief Operating Officer | Venta | 97.289 | $24,69 | $2,4M |
| 17/03/2026 | BECKLUND IRENE | Officer | Venta | 5.529 | $24,69 | $136,5K |
| 17/03/2026 | BOUGHTON SOLEIL | Officer | Venta | 4.812 | $24,69 | $118,8K |
| 27/02/2026 | BOUGHTON SOLEIL | Officer | Venta | 4.651 | $15,21 | $70,7K |
| 03/02/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 5.262 | $26,44 | $139,1K |
| 20/01/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 9.067 | $30,34 | $275,1K |
| 05/01/2026 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 9.070 | $33,79 | $306,5K |
| 22/12/2025 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 23.090 | $35,72 | $824,7K |
| 17/12/2025 | CHI MICHAEL Y | Chief Operating Officer | Venta | 13.750 | $36,71 | $504,8K |
| 17/12/2025 | CARROLL PATRICK HARRISON | Officer and Director | Venta | 10.021 | $36,71 | $367,9K |
| 17/12/2025 | AUTOR DEBORAH M | Officer and Director | Venta | 7.054 | $36,71 | $259,0K |
| 17/12/2025 | BECKLUND IRENE | Officer | Venta | 8.411 | $36,71 | $308,8K |
| 09/12/2025 | PEREZ GARCIA ANDREA G | Director | Venta | 2.500 | $39,17 | $97,9K |
| 24/11/2025 | BOUGHTON SOLEIL | Officer | Venta | 2.631 | $35,22 | $92,7K |
| 17/11/2025 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 23.187 | $36,81 | $853,5K |
| 10/11/2025 | BOUGHTON SOLEIL | Officer | Venta | 2.637 | $42,53 | $112,2K |
| 27/10/2025 | BOUGHTON SOLEIL | Officer | Venta | 2.637 | $50,10 | $132,1K |
| 17/10/2025 | OKUPE OLUYEMI | Chief Financial Officer | Venta | 11.592 | $57,13 | $662,2K |
| 16/10/2025 | DUDUM ANDREW | Chief Executive Officer | Venta | 175.661 | $62,79 | $11,0M |
Holders Institucionales
Datos al 31/08/2026
Principales tenedores institucionales por valor de la posición.
| Holder | Tipo | % del flotante | Acciones | Valor | Reportado |
|---|---|---|---|---|---|
| Blackrock Inc. | Institución | 0,13% | 28.703.514 | $764,4 M | 30/06/2026 |
| Vanguard Portfolio Management LLC | Institución | 0,05% | 10.559.314 | $281,2 M | 30/06/2026 |
| Vanguard Capital Management LLC | Institución | 0,04% | 9.541.384 | $254,1 M | 30/06/2026 |
| State Street Corporation | Institución | 0,04% | 8.145.699 | $216,9 M | 30/06/2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | Fondo | 0,03% | 7.422.263 | $197,7 M | 31/08/2026 |
| Morgan Stanley | Institución | 0,03% | 7.152.498 | $190,5 M | 30/06/2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | Fondo | 0,03% | 6.715.813 | $178,8 M | 30/06/2026 |
| Divisadero Street Capital Management, LP | Institución | 0,03% | 6.009.505 | $160 M | 30/06/2026 |
| Geode Capital Management, LLC | Institución | 0,03% | 5.681.832 | $151,3 M | 30/06/2026 |
| iShares Trust-iShares Russell 2000 ETF | Fondo | 0,02% | 5.498.189 | $146,4 M | 31/08/2026 |
Comparación con Pares
Métricas de valuación y rentabilidad de la empresa frente a sus pares de industria. La empresa analizada aparece destacada en la primera fila.
| Empresa | Market Cap | P/E | EV/EBITDA | P/S | ROE | Margen Op. |
|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc.Esta empresa | $6.931,7 M | N/A | -704,79x | 2,41x | -32,03% | -12,75% |
ZTS Zoetis Inc. | $32.574,4 M | 12,80x | N/A | 3,62x | N/A | 36,34% |
VTRS Viatris Inc. | $20.031,4 M | N/A | 8,23x | 1,36x | -1,96% | -0,57% |